The β3-AR blockade was found to prevent hypoxia-induced VEGF accumulation, and similarly, in mice bearing melanoma cells, β3-AR antagonism tackled tumor growth and vascularization [17], decreasing the NO production [18]. This evidence concerns the gene ADRB3 and melanoma.